JAMIE SCHANZ: Open Payments
NPI 1649952888 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,577 in 37 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $1,577
Food & beverage: $1,416Education: $161
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $562 |
| Incyte Corporation | 2 | $190 |
| PFIZER INC. | 1 | $125 |
| BeiGene USA, Inc. | 1 | $120 |
| Lilly USA, LLC | 1 | $96 |
| Daiichi Sankyo Inc. | 3 | $85 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| BeOne Medicines USA, Inc. | 2 | $50 |
| Celgene Corporation | 1 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
Products named: RYBREVANT, CARVYKTI, BRUKINSA, Niktimvo, TALVEY, VERZENIO, Vanflyta, BLENREP.
Industry payments across IL — which companies pay providers there.
